Economic burden of non-malignant blood disorders across Europe: A population-based cost study
Background: Blood disorders comprise a wide range of diseases including anaemia, malignant blood disorders, and haemorrhagic disorders. Although they are a common cause of disease, no systematic cost-of-illness studies have been done to assess the economic effect of non-malignant blood disorders in...
Main Authors: | Luengo-Fernandez, R, Burns, R, Leal, J |
---|---|
Format: | Journal article |
Published: |
Elsevier
2016
|
Similar Items
-
Economic burden of malignant blood disorders across Europe: A population-based cost analysis
by: Burns, R, et al.
Published: (2016) -
Economic burden of stroke across Europe: a population-based cost analysis
by: Luengo-Fernandez, R, et al.
Published: (2019) -
Economic burden of cancer across the European Union: A population-based cost analysis
by: Luengo-Fernandez, R, et al.
Published: (2013) -
Economic burden of cancer across the European Union: a population-based cost analysis.
by: Luengo-Fernandez, R, et al.
Published: (2013) -
Economic burden of CVD across the European Union: trends over the last decade
by: Leal, J, et al.
Published: (2017)